Pricing
  1. JP-listed companies
  2. Euglena Co., Ltd.
  3. Financials
  4. Total liabilities

Euglena Co., Ltd. (2931)

Market cap
¥57.8B
P/E ratio
Develops health foods, cosmetics, and biofuels using Euglena microalgae through proprietary large-scale cultivation technology across healthcare and sustainable energy markets.
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndTotal liabilities (Million JPY)YoY (%)
Dec 31, 202543,805+6.47%
Dec 31, 202441,142+4.41%
Dec 31, 202339,404+3.91%
Dec 31, 202237,921-6.18%
Dec 31, 202140,419-3.48%
Sep 30, 202141,878+602.15%
Sep 30, 20205,964-6.30%
Sep 30, 20196,365+7.29%
Sep 30, 20185,933+85.24%
Sep 30, 20173,203+52.28%
Sep 30, 20162,103+15.44%
Sep 30, 20151,822+118.21%
Sep 30, 2014835

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat